Member Directory

Established by Trinity College in 1970, Cambridge Science Park is the UK’s oldest and most prestigious science park.. . Now home to over 100 companies and 1,650,000 sq ft of buildings, Cambridge Science Park continues to attract new businesses, from small start-ups and spin-outs to subsidiaries of multinational corporations.. . For further information please visit

The United Kingdom is by far Canada’s most important commercial partner in Europe and, from a global perspective, ranks second only to the United States. Two-way trade between Canada and UK was valued at more than £12 billion in 2008. The UK ranks second in Foreign Direct Investment (FDI), with UK FDI stock in Canada valued at an all time high of £22 billion in 2008. The UK is also Canada’s second largest science & technology partner worldwide, with over 40% of S&T collaborations being in the field of biomedical and clinical research. . . The Commercial and Economic Division of the Canadian High Commission in London works with Canadian companies, universities and research institutes that are seeking market opportunities, collaborative R&D partnerships or technology transfer deals in the UK. We also offer confidential advice and service to UK companies interested in investing in Canada or in finding collaborative opportunities with Canadian partners.

Cancer Research Horizons is the innovation engine of Cancer Research UK – the world’s largest charitable funder of cancer research. We bring together the best minds, bold ideas, and the right partners to bridge the gap between academic research and taking drugs to market. We focus on the tougher, more profound ideas that can lead to true innovation, translating them into effective treatments and diagnostics for cancer patients.

To date we’ve played an instrumental role in forming over 70 startup companies. We’ve helped bring 11 cancer drugs to market, borne out of Cancer Research UK’s pioneering research. Through these drugs, we have enabled in excess of 6 million courses of treatment for cancer patients worldwide.

With access to Cancer Research UK’s network of 4,000 exceptional researchers, and over £400m of annual research spend, we’re a powerful partner in the fight to conquer cancer. By uniting our commercial partnerships and therapeutic innovation capabilities, Cancer Research Horizons is uniquely placed to support translational funding, entrepreneurial development, licensing and collaboration, start-up creation, and offer a full spectrum of drug discovery and clinical capabilities.

Every penny we make goes back into funding the next bold steps, to help bring forward the day when all cancers and conquered.

Cancer Research Technology (CRT) is dedicated to advancing discoveries to beat cancer. We develop and commercialise exciting new discoveries in cancer research, working closely with leading clinical and academic institutions, pharmaceutical companies and biotechs worldwide. CRT facilitates the discovery, development and marketing of new cancer therapeutics, vaccines, diagnostics and enabling technologies. . . CRT is owned by Cancer Research UK, the world’s largest charitable funder of cancer research and we’re uniquely placed to capitalise on the research and connections of our parent organisation.

Carocell Bio are developing novel peptides to more safely and effectively treat inflammatory diseases.

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years’ industry experience, Catalent has the proven expertise, superior technologies and flexible solutions at the right scale to help ensure successful product development, launch, tech transfer and reliable global clinical and commercial supply. Our team of approximately 15,000 people, at +45 sites, supplies over 73 billion doses of +7,000 products for more than 1,000 customers – or 1 in 20 doses taken by patients globally. At Catalent, we combine deep expertise in the science of drug development and manufacturing with the art of crafting better treatments to deliver successful medicines for our customers and their patients faster.™
Watch our Member Showcase video here

Discovery services in oncology, immunology and respiratory